drugset / Trial / NCT06485661

Effect of Captopril on GLS in Duchenne Myodystrophy

NCT06485661

Phase 0 Unknown 20 enrolled Ain Shams University
NaSingle-groupOpen-labelTreatment

Summary

To outline the intermediate term effect of prescribing Captopril as an add on therapy on Left ventricular functions as measured by Global longitudinal strain in patients with Duchenne myodystrophy (DMD)

Timeline

Start
2024-01-01
Primary completion
2024-09-30
Completion
2024-09-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Captopril Small molecule

Indications

No indication recorded.